The groundbreaking EsoGuard DNA test is changing the way esophageal precancer is detected. Now disease can be identified in a simple office-based visit without endoscopy.

TissueCypher is the first AI-driven precision medicine test to determine a patient’s individual risk of progression from Barrett's Esophagus to cancer.

Striving to provide comprehensive gastrointestinal and liver care, from acid reflux, celiac disease and colon cancer screening to advanced liver and pancreatic diseases.